Prevalence of Leishmaniasis among Blood Donors: A Systematic Review and Meta-Analysis

被引:1
作者
Kantzanou, Maria [1 ]
Kostares, Evangelos [1 ]
Kostare, Georgia [1 ]
Papagiannopoulou, Evangelia [1 ]
Kostares, Michael [2 ]
Tsakris, Athanasios [2 ]
机构
[1] Natl & Kapodistrian Univ Athens, Med Sch, Dept Microbiol, Athens 11527, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Dept Anat, Athens 11527, Greece
关键词
leishmaniasis; blood donors; prevalence; PCR; serological analysis; meta-analysis; INFANTUM INFECTION; DONOVANI INFECTION; ENDEMIC AREA; ANTIBODIES; BANK; SEROPREVALENCE; DISTRICT; REGION; RISK;
D O I
10.3390/diseases12070160
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Our study seeks to provide a comprehensive assessment of leishmaniasis prevalence among blood donors, employing rigorous methodologies to inform public health initiatives and transfusion safety measures. A thorough literature search was conducted using electronic databases (Medline, Scopus, Web of Science, and Google Scholar) to identify the relevant studies reporting the prevalence of leishmaniasis among blood donors, gathering a wide range of studies encompassing different geographic locations and time periods. The pooled prevalence with a 95% confidence interval (CI) was estimated, and quality assessment, outlier analysis, and influential analysis were performed to ensure the robustness and validity of the findings. Our search and subsequent analyses led to the inclusion of thirty-five studies in our review. Using molecular diagnostic methods, the prevalence was estimated at 2.3% (95% CI 1-3.9%), while serological diagnostic methods indicated a higher prevalence rate of 4.5% (95% CI 2.8-6.7%). Notably, we observed significant heterogeneity among the included studies for each analysis. The observed heterogeneity highlights the need for future research to delve into the factors influencing leishmaniasis prevalence, with prospective and retrospective studies addressing the limitations identified in this review.
引用
收藏
页数:15
相关论文
共 60 条
[1]  
Abdon F.M., 2020, Infect. Dis. Trop. Med, V6, pe592, DOI [10.32113/idtm20203592, DOI 10.32113/IDTM20203592]
[2]  
Ali SO, 2019, INT J MED RES HEALTH, V8, P104
[3]   Asymptomatic Leishmania infection in blood donors from the Southern of Spain [J].
Aliaga, Luis ;
Ceballos, Julian ;
Sampedro, Antonio ;
Cobo, Fernando ;
Angel Lopez-Nevot, Miguel ;
Merino-Espinosa, Gemma ;
Morillas-Marquez, Francisco ;
Martin-Sanchez, Joaquina .
INFECTION, 2019, 47 (05) :739-747
[4]  
[Anonymous], NEWCASTLE-OTTAWA QUALITY ASSESSMENT SCALE CASE CONTROL STUDIES
[5]  
[Anonymous], Prevention CC for DC and. CDC-Leishmaniasis-Epidemiology & Risk Factors 2020
[6]  
[Anonymous], Ensure That There Are Adequate Studies
[7]  
[Anonymous], SCHISTOSOMIASIS
[8]  
Aronson N, 2016, CLIN INFECT DIS, V63, pE202, DOI [10.1093/cid/ciw670, 10.1093/cid/ciw742]
[9]   A Convenient and Sensitive kDNA-PCR for Screening of Leishmania infantum Latent Infection Among Blood Donors in a Highly Endemic Focus, Northwestern Iran [J].
Asfaram, Shabnam ;
Fakhar, Mahdi ;
Mohebali, Mehdi ;
Hezarjaribi, Hajar Ziaei ;
Mardani, Ahmad ;
Ghezelbash, Behrooz ;
Akhoundi, Behnaz ;
Zarei, Zabihollah ;
Moazeni, Maryam .
ACTA PARASITOLOGICA, 2022, 67 (02) :842-850
[10]   Global status of visceral leishmanial infection among blood donors: A systematic review and meta-analysis [J].
Asfaram, Shabnam ;
Fakhar, Mandi ;
Soosaraei, Masoud ;
Teshnizi, Saeed Hosseini ;
Mardani, Ahmad ;
Banimostafavi, Elham Sadat ;
Hezarjaribi, Hajar Ziaei .
TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (05) :748-754